You are here: Industry Insights > Copaxone

News List

Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA fiercepharma
August 18, 2019
Dr. Reddy’s, which has been dealing with repeated manufacturing setbacks from the FDA, is now facing a new regulatory challenge.
Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA fiercepharma
August 15, 2019
Dr. Reddy’s, which has been dealing with repeated manufacturing setbacks from the FDA, is now facing a new regulatory challenge.
Teva's Copaxone holds its own in wake of Mylan's generic price cut fiercepharma
August 03, 2018
Mylan may have toppled list prices on its generic Copaxone, but Teva isn’t worried. After far surpassing quarterly expectations for the multiple sclerosis blockbuster in the second quarter, the Israeli drugmaker says it’s still on track to rake in signifi
Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already fiercepharma
July 17, 2018
Thanks to Mylan’s gigantic price cut on generic Copaxone from earlier this month, Teva’s going to have to take the price on its branded product down. And it would be wise to start now, one analyst says.
Cutting costs and Copaxone prices pays off for Teva, sending shares skyward fiercepharma
May 04, 2018
You could say Teva investors are pleasantly surprised. The embattled drugmaker's shares soared 8% in premarket trading Thursday after it unexpectedly raised guidance for the year...
Synthon’s generic version of Copaxone at 40mg receives European approval to treat MS pharmaceufical-technology
October 09, 2017
MS is an unpredictable, often disabling disease of the central nervous system that disturbs the flow of information within the brain, and between the brain and body.